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Changes of brain nitric oxide production in experimental
cerebral ischemia
H. Zhang, Y. Y. Hu and S. X. Murong
Psychology Department, University of Michigan, Ann Arbor,
MI 48109, USA
In order to study the role of nitric oxide (NO) in ischemic brain injury. Global
cerebral ischemia was established in SD rats by modified Pulsinelli’s method.
The activities of constitutive nitric oxide synthase (cNOS), inducible NOS
(iNOS), neuronal NOS (nNOS), nitrite (NO2) and cyclic GMP in cerebral
cortex, hippocampus, striatum and cerebellum at different time intervals were
measured by radioimmunoassy, NADPH-d histochemistry and fluorometry
methods. The results showed that the activities of cNOS increased at 5 min
in four regions and decreased in cortex, hippocampus and striatum at 60 min,
in cerebellum at 15 min iNOS increased in cortex and striatum at 15 min, in
hippocampus and cerebellum at 10 min, and persisted to 60 min. The
expression of nNOS increased after 5 min ischemia in cortex, striatum and
hippocampus, and return to normal at 30–60 min. The NO2 and cGMP also
increased after 5–15 min ischemia and returned to normal after 30–60 min
ischemia. These results indicated that the NO participated in the pathogenesis
of cerebral ischemia injury and different types of NOS play different role in
the cerebral ischemia injuries. Selected specific NOS inhibitors to decreased
the excessive production of NO at early stage may help to decrease the
ischemic injury.
CP13-02
Neuroprotection of mild hypothermia beginning
at different time intervals on cerebral
ischemia/reperfusion injury
H. Zhang and E. T. Tong
Psychology Department, University of Michigan, Ann Arbor,
MI 48109, USA
The effects of mild hypothermia beginning at different time intervals on
cerebral ischemia was studied in SD rats which were divided into sham-
operated, normothermia (37–38C) ischemia and mild hypothermia
(31–32C) group. The latter was subdivided into: 240 min hypothermia,
30 min normothermia plus 210 min hypothermia, 60 min normothermia plus
180 min hypothermia and 90 min normothermia plus 150 min hypothermia.
Global cerebral ischemia was induced by modified 4-vessel occlusion model.
240 min reperfusion following 20 min cerebral ischemia. Results showed
that in normothermia group, the amount of SOD, GSH-Px, GSH, ATP, K+
were lower and MDA, lactate, water content, Ca++ were higher than those in
sham-operated group. Mild hypothermia beginning immediately within
60 min delayed the consumption of SOD, GSH-Px, GSH, ATP and
decreased the accumulation of MDA, lactate, water content and Ca++ as
compared with normothermia group. Mild hypothermia beginning immedi-
ately within 30 min significantly decreased the elevation of Na+, Ca++ and
increased K+ in brain tissue when compared with normothermia. Mild
hypothermia beginning immediately at 90 min has little effect on the content
of SOD, GSH-Px, GSH, MDA, lactate, ATP, water content and Na+, K+,
Ca++ as compared with the normothermia group. Mild brain hypothermia
beginning immediately after ischemia delay consumption of endogenous
antioxidant enzyme and energy metabolism, decrease accumulation of lactate
and lipid peroxidation and the development of brain edema, which is
involved in the mechanism of cerebral protection by mild hypothermia. Mild
hypothermia limits ischemia injury beginning immediately within 30 or
60 min, but lost its function when beginning at 90 min following ischemia.
CP13-03
Novel mediators of ischemic preconditioning induced
neuroprotection
V. K. Dhodda, K. Sailor, R. J. Dempsey and R. L. R. Vemuganti
Department of Neurological Surgery, University of Wisconsin
Medical School, Madison, WI 53792, USA
A brief ischemic episode induces protection against a subsequent severe
ischemic insult. This phenomenon, known as ischemic preconditioning (PC)
might be mediated by the activation of several genes of the second messenger
signalling pathways. A 60-min transient middle cerebral artery occlusion
(MCAO) in adult, SHR rats results in an infarct encompassing cerebral
cortex and striatum by 24 h reperfusion. Present study observed that a 10-
min PC, 3 days before the 60 min transient MCAO, results in a 30%
reduction in the infarct volume. To understand the molecular mechanisms of
the PC induced neuroprotection, we analyzed the mRNA expression profiles
of rat cerebral cortex at 6, 24 and 72 h after a 10-min transient MCAO by
using Affymetrix GeneChip and real-time PCR. Expression of the members
of TGF-b signalling (TGF-b1, p 38 MAP kinase, Smad 1 and Smad 7) is
observed to be up-regulated after PC. This pathway plays an essential role in
tissue repair and immune homeostasis, but not hitherto implicated in PC
induced neuroprotection. TGF-b1 enhances Smad transcriptional activity
through activation of P38 gene expression to induce neuroprotection.
Consistent with previous studies, expression of several neuroprotective genes
including HSP70, HSP27, HO-1, MT-1/MT-2 and IL-6, were also observed
to be up-regulated after PC. These studies shows that TGF-b1/p38 MAP-
kinase signalling pathway is a promising target for developing drugs to limit
ischemic neuronal damage.
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Superoxide activates synaptic particulate nitric oxide
synthase: implications for superoxide signalling
and neurotoxicity
T. D. Foley, D. B. McPherson and R. P. Kilker
University of Scranton, Scranton, PA, USA
Mounting evidence supports the view that nitric oxide may protect against
superoxide-induced oxidative damage by mechanisms involving nitrosyla-
tion, direct scavenging of oxygen radicals including superoxide, and
up-regulation of antioxidant enzymes. However, the ability of neurons to
respond to superoxide by increasing nitric oxide synthesis is unknown. We
report here that superoxide, added as potassium superoxide (KO2), produced
a rapid activation (up to 12-fold) of nitric oxide synthase (NOS), measured
by the conversion of [3H]arginine to [3H]citrulline, and nitrite production in
a synaptic particulate fraction from rat brain cerebral cortex. Stimulation of
NOS by KO2 required the presence of ATP, which by itself inhibited basal
NOS activity. Decayed KO2 or authentic hydrogen peroxide did not increase
NOS activity and, importantly, activation of NOS by KO2 was blocked by
addition of superoxide dismutase. In addition, stimulation of NOS activity by
KO2 was abolished by the NOS inhibitor N-monomethyl-L-arginine and
EGTA but only partially reduced by the neuronal NOS inhibitor
7-nitroindazole. These findings are the first to demonstrate directly that
superoxide activates a synaptic NOS isoform. The nature of the particulate
fraction, the experimental conditions, and the low sensitivity to 7-nitroin-
dazole strongly suggest that superoxide activated mitochondrial NOS
(mtNOS). We propose that activation of the particulate NOS by superoxide
reflects a novel mitochondrial response that may contribute to neuronal
oxidant defenses although chronic activation of NOS under conditions of
superoxide generation may produce toxic quantities of peroxynitrite and
other reactive nitrogen oxides.
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PARP-1 activation causes mitochondrial dysfunction
R. A. Swanson, W. Ying, C. C. Alano and Y. Chen
Veterans Affairs Medical Center and University of California,
San Francisco, CA, USA
When activated by DNA damage, PARP1 consumes NAD+ to form
ADP-ribose polymers on acceptor proteins. Excessive PARP1 activation
during oxidative DNA damage is known to cause NAD+ depletion and cell
death, but the intervening steps are not well understood. Sustained inhibition
of the NAD+-dependent step in glycolysis is a potential consequence of
NAD+ depletion. If this occurs, it should be possible to rescue cells from
PARP1-mediated cell death by supplying alternative substrates for the
mitochondrial tricarboxylic acid cycle. PARP1 was activated in cortical
astrocyte and astrocyte-neuron cocultures with the DNA alkylating agent,
N-methyl-N¢-nitro-N-nitrosoguanidine (MNNG). Studies using the 2-deoxy-
glucose method confirmed a sustained reduction in glycolytic flux, and
studies with the JC-1 and TMRM indicate mitochondrial membrane
depolarization. The addition of 1 mM of a-ketoglutarate or 1 mM pyruvate
after washout of MNNG reduced cell death from 60 to 80% to near control
levels, while addition of PARP inhibitors or excess glucose after MNNG
washout had negligible effect. Cytoprotective effects remained significant
with substrate delivery delayed up to 3 h after MNNG washout. The findings
suggest that impaired glycolytic flux is a major factor in PARP1-mediated
cell death, and suggest that supply of alternative mitochondrial substrates
may be a promising strategy for delayed treatment of PARP1-mediated cell
death in ischemia and other disorders.
CP13-06
Oxidative modification of mitochondrial proteins
and cell death in Parkinson’s disease
W. Maruyama and M. Naoi
Institute for Longevity Sciences, Obu, Aichi, 474-8522, Institute
of Applied Biochemistry, Mitake, Gifu, 505-0116, Japan
Oxidative stress is one of the cell death mechanisms in neurodegenerative
disorders, such as Parkinson’s disease (PD) and Alzheimer’s disease. Most of
reactive oxygen species (ROS) generate in mitochondria through oxidative
phosphorylation, and a part of them are not scavenged by antioxidative
system and react with bioactive molecules. Recently, alpha-synuclein
containing nitrotyrosine, a marker for oxidative modification by peroxyni-
trite, was identified in Lewy body. In addition, inhibitors of mitochondrial
respiratory chain were reported to induce formation of Lewy body-like
inclusion in vivo and in vitro. In this paper it was examined whether ROS and
reactive nitrogen species (RNS) generated in mitochondria oxidize mito-
chondrial respiratory enzymes and induce the formation of inclusion body
and cell death in PD. Human neuroblastoma SH-SY5Y cells were treated
with a peroxynitrite donor, SIN-1, or an inhibitor of complex I, rotenone.
After the treatment, proteins modified with toxic aldehydes, 4-hydroxynon-
enal and acrolein, and containing nitrotyrosine were analyzed by immuno-
blotting. Particularly in mitochondrial fraction, the oxidized protein was
characterized by two-dimensional immunoblotting. Most of the oxidized
proteins were detected in subunits proteins of complex I. These results
indicate that mitochondrial complex I is a main target of oxidative stress in
dopamine neurons and its dysfunction may be involved in the death
mechanism in neurodegenerative disorders.
CP13-07
Induction of tissue transglutaminase in response
to ischemic brain injury
D. S. Wang, P. J. Tolentino, T. Fan, B. R. Pike, K. K. W. Wang,
A. L. Day and R. L. Hayes
McKnight Brain Institute, University of Florida, Gainesville,
FL 32610, USA
Tissue transglutaminase (tTG) is a member of the transglutaminase family
that catalyzes the post-translational modification of proteins by inserting
isopeptide bond within or between polypeptide chains in a Ca++ dependent
manner. Although tTG is known to be involved in cell growth, apoptosis and
neurodegeneration, the role of tTG in traumatic and ischemic brain injury
(TBI and IBI) is largely unknown. Previously, we showed that tTG was
up-regulated at mRNA and protein levels after TBI in rats. Although TBI and
IBI can result in some common pathological sequelae, there are many
important differences. Thus, we hypothesized that tTG message and protein
is up-regulated after transient middle cerebral artery occlusion (MCAO), and
that the magnitude and temporal expression differ from TBI. tTG protein and
mRNA of ipsi-cortex and hippocampus from rats of 0, 1, 3, 5 and 7 days
after MCAO were quantified by Western blot and real time PCR with tissues
from similar contra-lateral areas as controls. Results showed that tTG mRNA
in ipsi-cortex increased steadily from 1 to 5 days (1.5–10 fold of control
level) after MCAO and dropped to control level by 7 days. In ipsi-
hippocampus, tTG mRNA increased 2 fold of control at 1 day after MCAO
and gradually returned to control level by 7 days. tTG protein levels for both
ipsi-cortex and ipsi-hippocampus increased steadily during the experiment
with a more significant increase in cortex (5.5 fold in ipsi-cortex vs. 2 fold
in ipsi-hippocampus). Levels of tTG mRNA and protein of control tissues
were unchanged. These results indicate that tTG after MCAO in cortex and
hippocampus is up-regulated in a similar pattern to those in TBI brains.
Studies of functional significance of tTG after ischemia and TBI are
underway.
CP13-08
Role of oxidative stress in the ammonia-induced
mitochondrial permeability transition in cultured
astrocytes
A. R. Jayakumar, K. V. Rama Rao, G. Bai and M. D. Norenberg
Veterans Affairs Medical Center and Department of Pathology,
University of Miami School of Medicine, Miami, FL 33101, USA
Ammonia is the principal neurotoxin implicated in the pathogenesis of
hepatic encephalopathy (HE). The mechanisms of ammonia toxicity are
unclear, but appear to involve oxidative stress and mitochondrial dysfunction.
Astrocytes appear to be cell mainly affected. We have previously shown that
ammonia increases the production of reactive oxygen species (ROS), and that
it also induces the mitochondrial permeability transition (MPT) in cultured
astrocytes. Since ROS is a factor commonly implicated in the induction of the
MPT, we investigated the role of oxidative stress in the induction of the MPT
by ammonia. We therefore examined the effects of various antioxidants on
the induction by ammonia of the MPT in cultured astrocytes. Astrocytes were
subjected to NH4Cl (5 mM) treatment for two days alone or with various
antioxidants. The MPTwas assessed by 2-deoxyglucose (2-DG) permeability
into mitochondria, and by changes in the mitochondrial membrane potential
(DYm) by confocal microscopy using the potentiometric dye JC-1. Astrocytes
treated with ammonia significantly increased 2-DG permeability (90%,
p < 0.01) and concomitantly dissipated the DYm (60%, p < 0.01), consistent
with the induction of the MPT. The antioxidants superoxide dismutase (by
50%, p < 0.05), vitamin E (by 80%, p < 0.01), and the spin trapping agent
PBN (by 80%, p < 0.01), all significantly blocked the increase in 2-DG
permeability and the dissipation of the DYm produced by ammonia. These
data demonstrate the induction of the MPT by ammonia and suggest the
involvement of ROS in this process. Increased oxidative stress and
subsequent induction of the MPT by ammonia in astrocytes may contribute
to the pathogenesis of HE.
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CP13-09
Acidification-induced changes in Cx43 protein–protein
interactions
H. S. Duffy, P. Sorgen, W. Coombs, S. Taffet, M. Girvin,
M. Delmar and D. C. Spray
*AECOM, Bronx, NY 10464; SUNY Upstate Medical University,
Syracuse, NY 13210, USA
Astrocytic gap junctions close in response to low intracellular pH, a process
that may occur during ischemia. We propose that pH gating of Connexin43
(Cx43) involves binding of the carboxyl terminal domain (Cx43CT) to a
pore-affiliated receptor and, possibly, interaction of Cx43 with other
molecular partners. We studied the role of intra– and intermolecular
interactions in Cx43 pH gating. Peptides were made corresponding to
intracellular regions of Cx43. Using Surface Plasmon resonance (SPR) we
found pH dependent binding of the second half of the cytoplasmic loop to
Cx43CT (Kd ¼ 80 and 225 mM, pH 6.5 and 7.4, respectively). Binding was
inhibited by preincubation with a synthetic peptide from region 346–362 of
Cx43CT and by an antibody to this epitope, suggesting the binding site lies
partially within this region. Nuclear magnetic resonance (NMR) studies
showed formation of alpha helices in response to low pH in amino acid
sequences VEMHL (aa 123–127) and IEEHGK (aa 139–143) in the loop, and
a helical region within the suggested Cx43CT binding site. In addition, we
found that acidification of astrocytes in vitro led to dissociation of Cx43 from
its scaffold protein ZO-1. SPR showed that this was not due to pH
dependence of Cx43-ZO-1 interaction (Kd ¼ 2.23 mM at pH 7.4, 1.71 mM at
pH 6.5) but to a strong pH–dependent interaction of Cx43 with c-Src
(Kd ¼ 0.63 mM at pH 7.4, 0.04 mM at pH 6.5) which caused ZO-1 to
dissociate from Cx43CT. Separate experiments showed activation of
astrocytic src at low pH. These changes in the composition of the Cx43
Nexus may play a major role in limiting tissue damage during brain ischemia.
Acknowledgements: Supported by NIH grants NS 07098 (HSD) NS34931
& NS41282 (DCS) and GM57691 (MD).
CP13-10
Sphingolipids in rat model of transient focal cerebral
ischemia: implication for stroke injury
M. Khan, B. K. Sekhon, C. S. Sekhon, I. Singh and A. K. Singh
Department of Pediatrics, Medical University of South Carolina,
Charleston, SC 29425, USA
Lipids are essential for signal transduction in response to trauma leading to
neurodegeneration. Ceramide is an important mediator of apoptosis and cell
proliferation. We studied the involvement of ceramide/sphingomyelin
pathway in rat brain (stroke model) after 45 min ischemia followed by
24-h reperfusion. Ischemia was performed through occlusion of right middle
cerebral artery (MCA). The level of ceramide was found increased (70–100%
in ischemic side of brain v/s contralateral side of brain). Sphingomyelin
levels were also decreased by 20–25% in ischemic brain v/s contralateral side
of brain. Increase in ceramide and decrease in sphingomyelin were in good
agreement with observed apoptotic cell loss (TUNEL assay) and decrease in
the level of cardiolipin (a mitochondrian specific phospholipids) in affected
ischemic brain. N-acetyl cysteine (NAC), a therapeutic agent recognized as
potent antioxidant provided protective effect. Pretreatment with NAC before
ischemia reduced the infarct volume size, suppressed apoptosis, restored
cardiolipin level and decreased the levels of free fatty acids. However, NAC
did not normalize the ceramide level. These interesting observations raise a
question about the role of ceramide and its relationship with apoptosis and
oxidative stress in rat brain ischemia.
Acknowledgements: Supported by NIH grants NS-40144, NS-40810,
NS-22576, NS-34741 and NS-37766.
CP13-11
Inhibition of peroxisomal functions and production
of excessive oxidative stress by psychosine in rat C6
glial cells
M. Khan, S. Giri, I. Singh and A. K. Singh
Department of Pediatrics, Medical University of South Carolina,
Charleston, SC 29403, USA
The primary defect of abnormality in the metabolism of psychosine in Krabbe
disease results in the loss of oligodendrocytes, increased oxidative stress,
inflammatory reactions and profound demyelination. To understand the basis
of toxicity of psychosine in the CNS of Krabbe disease, we examined the
effects of psychosine on the peroxisomal b-oxidation of very long chain fatty
acids (VLCFA), plasmalogen biosynthesis and on the production of reactive
oxygen/nitrogen species. Rat C6 glial cells were treated with psychosine
(2–10 mM) in absence and presence of cytokines (LPS + IFN-c, or TNF-a +
IL-1b) for 24 and 72 h. Psychosine inhibited peroxisomal b-oxidation of
VLCFA (30–40% decrease compared to control) and induced the accumu-
lation of VLCFA measured as levels of 26 : 0 (100% increase compared to
control). Furthermore, psychosine treatment decreased the levels of plasmal-
ogens (35–50% decrease compared to control). Plasmalogens levels were also
drastically low in Krabbe brain than normal control brain. Psychosine also
potentiated the known cytokine-induced inhibition of peroxisomal b-oxida-
tion, accumulation of VLCFA and NO production. We also measured overall
oxidative stress using dichlorofluorescin diacetate in psychosine-treated cells
and found 1–2 fold increase in oxidative stress production. Both psychosine-
mediated loss of peroxisomal functions as well as ROS production could be
inhibited by antioxidant, N-acetylcysteine. Our results suggest that inhibition
of peroxisomal functions and increased free radical production by psychosine
may be responsible, at least in part, for the loss of oligodendrocytes and break
down of myelin in Krabbe brain.
Acknowledgements: Supported by NIH grants NS-40144, NS-40810,
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CP13-12
Diazepam prevents changes in intracellular Cl) and Ca2+
and restores neuronal activity after ischemia in vitro
F. Galeffi, R. Sah and R. D. Schwartz-Bloom
Department of Pharmacology, Duke University Medical Center,
Durham, NC 27710, USA
We have shown that diazepam (DZ) protects hippocampal neurons when
administered early after transient cerebral ischemia. To examine mechanisms
of DZ action, in the absence of systemic effects, we used an in vitro model of
ischemia [oxygen-glucose deprivation (OGD)] in the adult hippocampal
slice. We are interested in determining if DZ can prevent upstream events
such as loss of ionic homeostasis and its consequences on neuronal
transmission. We measured the effect of OGD on changes in intracellular
Cl) and Ca2+. Application of DZ after OGD prevented the increase in
intracellular Cl) in area CA1 pyramidal neurons, measured by optical
imaging with the Cl) sensitive fluorescent probe, MEQ. The increase in
intracellular Cl) after OGD led to a reduction in GABA responses 2 h later,
measured in the presence of the GABA agonist, muscimol. When DZ was
added for 1 h after OGD, muscimol responses were restored completely. To
measure changes in intracellular Ca2+ after OGD, we bath-loaded adult
hippocampal slices with calcium green-1 AM. OGD increased intracellular
Ca2+ in CA1 pyramidal neurons. The addition of DZ prior to OGD reduced
the increase in intracellular Ca2+ by approximately 50%. To determine the
effect of DZ on neuronal transmission within the hippocampus, we measured
field responses in area CA1 pyramidal neurons. Area CA1 population spikes
were suppressed by OGD and they did not recover 1 h later. When DZ was
included in the reoxygenation buffer for only 30 min, it restored the
population spike amplitude to within 85% of that in normal slices. Thus, after
OGD, DZ restores ionic homeostasis, preserves GABA responses and
restores neuronal activity within the hippocampus.
Acknowledgements: Supported by NIH grant #NS28791.
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Nitric oxide – mediated activation of ERK and JNK
during hypoxia in neuronal nuclei of newborn pigs
O. P. Miahra and Q. M. Ashraf
Department of Pediatrics, MCP Hahnemann University
and St Christopher’s Hospital for Children, Philadelphia, USA
The extracellular signal-regulated kinase (ERK) and c-Jun N-Terminal kinase
(JNK) phosphorylate antiapoptotic proteins thereby may regulate hypoxia-
induced programmed cell death. The present study tests the hypotheses that
hypoxia activates ERK and JNK in neuronal nuclei of newborn pigs and the
hypoxa-induced activation of ERK and JNK is mediated by nitric oxide
(NO). Activated ERK and JNK were assessed by determining phosphoryl-
ated ERK and JNK by immunoblotting in 6 normoxic (Nx), 10 hypoxic (Hx)
and 5 N-nitro-L-arginine (a NOS inhibitor)-treated (40 mg/kg) hypoxic
(NNLA-HX) 3–5-day-old-piglets. Animals were exposed to an FiO2 of
0.05–0.07 for 60 min Neuronal nuclei were isolated and nuclear proteins
were immunoblotted with antiphosphorylated ERK and JNK. Protein bands
were detected, analyzed and expressed as (OD · mm2). Tissue hypoxia was
documented by ATP levels. ATP levels were 4.45 ± 0.57, 1.16 ± 0.33 and
1.10 ± 0.25 lM/g br in Nx, Hx ( p < 0.001 vs. Nx) and NNLA-Hx
( p < 0.001 vs. Nx) groups, respectively. Phosphorylated ERK density was
170.5 ± 53.7 in Nx vs. 419.6 ± 63.9 in the Hx group ( p < 0.001) and
270.0 ± 28.7 in the NNLA-Hx group ( p < 0.002 vs. Hx). Density of
phosphorylated JNK was 172.8 ± 42.8 in the Nx vs. 364.6 ± 60.1 in the Hx
( p < 0.002 vs. Nx) and 254.8 ± 24.8 in the NNLA-Hx group (p < 0.002 vs.
Hx). We data demonstrate increased activation of ERK and JNK following
hypoxia. NNLA,a NOS inhibitor, decreased the hypoxia-induced activation
of ERK and JNK. We conclude that the hypoxia-induced activation of ERK
and JNK is NO-mediated.
Acknowledgements: Supported by NIH-HD-38079.
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Effect of neuronal NOS inhibitor, 7-nitro-indazole,
on cytosolic caspase 9 activity in vitro
O. P. Mishra
MCP Hahnemann University and St Christopher’s Hosp.
for Children, Philadelphia, USA
Previous studies have shown that nitric oxide synthase (NOS) inhibitors
prevent or reduce the hypoxia-induced neuronal injury. The present study
tests the hypothesis that neuronal NOS inhibitor, 7-nitro-indazole (7-NI) will
inhibit the cysteine protease, caspase 9, the initiator of programmed cell
death. The effect of 7 NI on caspase 9 activity was determined in the
cytosolic fraction of the cerebral cortex of normoxic (Nx, n ¼ 4) and hypoxic
(Hx, n ¼ 4) newborn piglets. The animals were exposed to either 21% (Nx)
or 7% (Hx) oxygen for 60 min. Cerebral tissue hypoxia was documented by
the ATP and phosphocreatine levels. Cytosols were prepared and caspase 9
activity determined using a specific fluorogenic substrate (-Ac-Leu-Glu-His-
Asp-AFC) for caspase 9 and monitored at 400 nm excitation and 505 nm
emission wavelength. Caspase 9 activity in Nx group was 629 ± 49 as
compared to 960 ± 105 pmoles AFC/min/mg protein (p < 0.002, 50.2%
increase) in the Hx group. In presence of 10, 50 and 100 lM 7-NI, caspase 9
activity decreased to 459 ± 41, 252 ± 36 and 256 ± 29 pmoles/min/mg
protein, respectively, in Nx group. In Hx group, the activity decreased to
578 ± 49, 402 ± 37, 393 ± 35 pmoles/min/mg protein, respectively. The
data demonstrate that 7-NI inhibits caspase 9 in both the Nx and Hx groups.
It is concluded that 7-NI is an inhibitor of caspase 9. It is proposed that 7 NI
administration will be neuroprotective due to its properties as inhibitor of
nNOS as well as of caspase 9 and prevent the hypoxia-induced neuronal
death.
Acknowledgements: Supported by NIH-HD-38079.
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The glucose paradox of cerebral ischemia – a possible
resolution
A. Schurr and R. S. Payne
Department of Anesthesiology, University of Louisville School
of Medicine, Louisville, KY 40292, USA
The glucose paradox of cerebral ischemia, the aggravation of delayed
neuronal damage by preischemic hyperglycemia, is a well-documented
phenomenon. Recently, we demonstrated that corticosterone (CT) plasma
levels were significantly elevated within 30 min after glucose administration
(i.p.) only to return to baseline levels by 120 min. In this study we examined
the postulate that preischemic glucose loading aggravates the postischemic
outcome via the induction of a short-lived, massive elevation in CT plasma
levels. Hence, we tested the ability of the CT synthesis inhibitor metyrapone
(MT) and the glucocorticoid receptor antagonist, mifepristone (RU486), to
attenuate the aggravated delayed neuronal damage in a rat model of cardiac-
arrest-induced transient global cerebral ischemia (TGI). Seven different
groups of 24-h-fasted rats were used and were administered several
treatments prior to TGI that were aimed at either inhibiting CT synthesis
(MT, 100 mg/kg, i.p.) or at blocking the brain glucocorticoid receptors
(RU486, 40 mg/kg, i.p.). Plasma glucose and CT levels were measured
2 min pre-TGI. Neuronal damage was assessed 7 days post-TGI in
hippocampal slices using electrophysiological means. Plasma glucose levels
were not reduced in MT- or RU486-treated rats. Both MT and RU 486
prevented preischemic hyperglycemia-aggravated ischemic damage, the
former presumably via inhibition of CT synthesis, the latter by glucocorticoid
receptor antagonism. The present data strongly suggest that preischemic
hyperglycemia-aggravated neuronal damage, i.e. the glucose paradox, results
from glucose-induced CT release, rather than intensification of lactic acidosis
in the ischemic brain.
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